NCLT meeting on Oct 27 for amalgamation of two group companies

Nclt Scheme FiledStrategic Transactions View source PDF Explain this filing

PRIVISCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.8%Reaction day

₹3430.30

prior close

₹3445.50

announcement price

In-mkt

timing

Nifty Microcap 250market+1.3%+1.4% vs market

Specialty Chemicals peers, median of 100sector+1.5%+1.2% vs sector

On the reaction day the stock moved 1.4 pts more than Nifty Microcap 250 and 1.2 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

-0.1

15m

-0.2

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.8+1.3+1.4+1.5+1.2

Next day

+2.6+1.1+1.5+1.8+0.7

+0.7-1.7+2.4-0.3+1.0

-0.4-1.5+1.0-0.4-0.0

-2.1-0.6-1.5-0.0-2.1

-1.0-0.4-0.6+0.2-1.2

-1.8-1.4-0.4+0.0-1.8

15d

+1.3-6.0+7.3-5.6+6.9

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 100Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Privi Speciality Chemicals has called an NCLT-convened shareholders meeting on October 27, 2026 to approve amalgamation of two group private firms, Privi Fine Sciences and Privi Biotechnologies, into itself. Privi Biotech is already a wholly owned subsidiary. Privi Fine Sciences shareholders will get 1 Privi share for every 135 held. Appointed date is October 1, 2025. Aimed at consolidating same-family promoted specialty chemicals businesses.

Likely market impact

Internal group restructuring. Minor share dilution from the 1 to 135 swap. Focus on synergies, cost savings, and simpler corporate structure.